Acute coronary syndromes

This article outlines the key changes in the new NICE guidance on ACS and highlights those of particular interest to primary care. It also includes three visual summaries.

Join OnMedica and benefit from:

  • Bitesize CPD and easy to digest content, free for UK-based GPs and specialist doctors
  • High-quality, evidence-based content developed by expert editors and clinicians
  • Articles, quizzes, videos, visual summaries and more
  • Regulatory alerts and round-up of medical journals
  • New content added daily, so you know you’re always up to date

Existing members Sign in


Go to the profile of Siddappa Gada
Siddappa Gada 3 months ago

Thanks for forwarding updated NICE guidelines. As good number of cases first present in primary care to their GPs. While waiting for ECGs / initial assessment / paramedic to arrive, It would benefit if there is clarity on which anti-platelets a primary care clinician should give and at what dose

Go to the profile of Luke Koupparis
Luke Koupparis 3 months ago

Dear Dr Gada, thank you for your comment. In section 1.2 the NICE guidance outlines initial drug therapy with dosing for those with unstable angina or NSTEMI.

Initial drug therapy

Offer aspirin as soon as possible to all people with unstable angina or non‑ST‑segment elevation myocardial infarction (NSTEMI) and continue indefinitely unless contraindicated by bleeding risk or aspirin hypersensitivity. [2010]

Offer people with unstable angina or NSTEMI a single loading dose of 300-mg aspirin as soon as possible unless there is clear evidence that they are allergic to it. [2010]